About Marcia L. Verduin, M.D.
Dr. Marcy Verduin is board-certified in Adult Psychiatry with added qualifications in Addictions. She has extensive experience with medical education, research and clinical practice, having served on the faculty at the Medical University of South Carolina in Charleston prior to joining the UCF College of Medicine. Her clinical and research interests include severe mental illness co-occurring with substance use disorders, with a primary focus on schizophrenia and bipolar disorder. She has served as the Principal Investigator or a Co-Investigator on several clinical and human laboratory trials, including a Career Development (K23) Award through the National Institute on Drug Abuse. Dr. Verduin has also held speaking engagements at national symposia and has served on the American Psychiatric Association’s Corresponding Committee on Training and Education in Addiction Psychiatry.
Dr. Verduin joined the UCF College of Medicine in August of 2007 as the Module Director for the Psychosocial Issues in Healthcare Module and the Director of the Psychiatry Clerkship (C-1). She now serves as an educator for the C-1 module and contributes to the development and implementation of the Mind and Body Module in Year 2, with a focus on psychopathology. She also plays a role in Student Affairs as the Associate Dean for Students.
Dr. Verduin was the Principal Investigator on a Robert Wood Johnson Foundation grant to design and examine the effect of interactive video games to help recovering alcoholics practice their relapse prevention skills. Her clinical work is based out of the Orlando VA Medical Center, where she is the Attending Psychiatrist for the Substance Abuse Residential Rehabilitation Treatment Program. She also serves as the Associate Book Editor for the Journal of Psychiatric Practice, on the Editorial Board for the FOCUS Self-Assessment Examination, and as an Ad Hoc Reviewer for several psychiatric and addictions journals.
McRae AL, Verduin ML, Tolliver BK, Carter RE, Herrin AE, Brady KT, Anderson SJ. An open-label trial of aripiprazole treatment in dual diagnosis individuals: safety and efficacy. J Dual Diagn, in press.
Tolliver BK, McRae AL, Verduin ML, Anderson SJ, Brady KT. Reversible elevation of triglycerides in dual diagnosis patients taking aripiprazole: a case series. J Clin Psychopharmacol 2008;28(4):464-7.
Gao K, Verduin ML, Kemp DE, Tolliver B, Ganocy SJ, Elhaj O, Brady K, Findling RL, Calabrese JR. Clinical Correlates of Patients with Rapid Cycling Bipolar Disorder and a Recent History of Substance Use Disorder: a Subtype Comparison. J Clin Psychiatry 2008;69(7):1057-63.
Brady KT, Verduin ML, Tolliver BK. Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep 2007;9(5):374-80.
Verduin ML, Upadhyaya H. Beating nicotine: medication algorithm helps teens quit. Current Psychiatry 2007;6(10):65-74.
Verduin ML. Ask the expert: treatment strategy for co-occurring bipolar disorder and alcohol abuse. FOCUS 2007;V(2):170-1.
Verduin ML, Payne RA, McRae AL, Back SE, Simpson SA, Sarang RY, Brady KT. Assessment of club drug use in a treatment-seeking sample of individuals with marijuana dependence. Am J Addict 2007;16:1-4.
Verduin ML, McKay S, Brady KT. Gabapentin in comorbid anxiety and substance use. Am J Addict 2007;16:1-2.
Brady KT, Tolliver BK, Verduin ML. Alcohol use and anxiety: diagnostic and management issues. Am J Psychiatry 2007;164:217-21.
Brady KT, Verduin ML. Pharmacotherapy of co-morbid mood, anxiety, and substance use disorders. Subst Use Misuse 2005; 40:2021-41.
Verduin ML, Carter RE, Brady KT, Myrick H, Timmerman M. Health service use among persons with comorbid bipolar and substance use disorders. Psychiatr Serv 2005; 56(4):475-80.
- Early Career Investigator Award, College on Problems of Drug Dependence
- Laughlin Fellow, American College of Psychiatrists
- Ginsberg Fellow, American Association of Directors of Psychiatric Residency Training
- PRITE Fellow, American College of Psychiatrists
- Golden Apple Award for Outstanding Lecturer in the Psychiatry Clerkship at the Medical University of South Carolina, 7 consecutive years